Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03384706 |
Other study ID # |
2017-1590 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
September 6, 2017 |
Est. completion date |
March 15, 2021 |
Study information
Verified date |
November 2022 |
Source |
University of Cincinnati |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The purpose of this research study is to compare the effectiveness of two treatments for the
symptoms of Posttraumatic Stress Disorder (PTSD) with a no therapy, wait-list control
condition. The two treatments are Cognitive Processing Therapy (CPT) as compared to
Accelerated Resolution Therapy (ART). Both have been found to be effective with veterans and
civilians in prior studies but they have never been compared to one another. Participants
will be 280 males and females ages 18 and older who meet criteria for PTSD (or subthreshold
PTSD). PTSD is a condition that can occur after a trauma experience such as combat, sexual
abuse, physical abuse, or natural disasters.
Description:
Objective(s): The primary aim of this study is to examine the effectiveness of two treatments
for the symptoms of Posttraumatic Stress Disorder (PTSD) with a no therapy, wait list control
condition. The two treatments are Cognitive Processing Therapy (CPT) as compared to
Accelerated Resolution Therapy (ART). Additional related symptoms of depression, anger,
sleep, and physical health will also be assessed. The study will involve both civilians and
veterans seeking outpatient therapy for PTSD. Data will be obtained via clinician structured
interviews and self-report measures.
Research Design: Participants will be recruited from the Cincinnati VA Medical Center, Trauma
Recovery Center (TRC), and at the University of Cincinnati (UC) Health Stress Center located
in Cincinnati, Ohio. All eligible participants will be randomized to receive CPT, ART, or
Wait List (WL) condition. For participants who are randomized to the WL condition, following
a period of seven weeks will be randomized into one of the two active treatment conditions,
CPT or ART. Participants in the two active treatment conditions will complete an assessment
at pre-treatment, post-treatment, 3 month, and 1 year follow-up.
Methodology: Participants will include 280 males and females ages 18 and older who meet
criteria for PTSD (or subthreshold PTSD). The investigators will contact potential
participants to determine eligibility for the study assessing inclusionary and exclusionary
criteria. All eligible participants will then be asked to complete a pre-treatment assessment
prior to being assigned their study treatment (CPT or ART or WL). Participants will receive a
full course of outpatient CPT or ART depending on their assigned study treatment. Once the
participant and treating clinician determine that therapy has been fully completed,
participants will complete a post-treatment assessment. Follow-up assessments will then be
completed 3-months and 1-year following the completion of therapy.
At each assessment participants will be asked to complete a series of self- and
clinic-reported measures that include assessments of PTSD symptoms, depression, general
mental health, pain, sleep habits, and health care utilization.
Findings: Not applicable at this time.
Clinical Relationships: The investigators anticipate that understanding the comparative
effectiveness between CPT and ART therapies will provide necessary information for care
provided to civilians and veterans suffering from PTSD.